BMS said Admilparant met its phase 3 goal in pulmonary fibrosis at 60 mg, but 120 mg missed. Data are topline. What patients and families should know.
Bristol Myers Pulmonary Fibrosis Drug Admilparant Met Main Goal at 60 mg, but Higher Dose Missed
by | Oct 15, 2026 | Uncategorized | 0 comments
Recent Comments